Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2

Clinical trial NCT03233828 · TERMINATED

Trial details

NCT number: NCT03233828
Sponsor: Carman Giacomantonio
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Melanoma (Skin)Melanoma in Situ

Start date: 2019-10-30
Primary completion: 2019-11-27
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.